about
The individual N- and C-lobes of calmodulin tether to the Cav1.2 channel and rescue the channel activity from run-down in ventricular myocytes of guinea-pig heartThe Ca(2+)-dependent interaction of calpastatin domain L with the C-terminal tail of the Cav1.2 channelDynamic alterations in the CaV1.2/CaM/CaMKII signaling pathway in the left ventricular myocardium of ischemic rat heartsGlutamate Deregulation in Ketamine-Induced Psychosis-A Potential Role of PSD95, NMDA Receptor and PMCA Interaction.Molecular cloning and expression of the calmodulin gene from guinea pig hearts.Abnormal alterations in the Ca²⁺/CaV1.2/calmodulin/caMKII signaling pathway in a tremor rat model and in cultured hippocampal neurons exposed to Mg²⁺-free solution.Expression of neonatal Nav1.5 in human brain astrocytoma and its effect on proliferation, invasion and apoptosis of astrocytoma cells.Aberrant changes of somatostatin and neuropeptide Y in brain of a genetic rat model for epilepsy: tremor rat.Metabolism and Metabolic Inhibition of Xanthotoxol in Human Liver Microsomes.Mg(2+)-dependent facilitation and inactivation of L-type Ca(2+) channels in guinea pig ventricular myocytes.Low-Mg(2+) treatment increases sensitivity of voltage-gated Na(+) channels to Ca(2+)/calmodulin-mediated modulation in cultured hippocampal neurons.Altered expression of neuropeptide Y, Y1 and Y2 receptors, but not Y5 receptor, within hippocampus and temporal lobe cortex of tremor rats.The alterations of Ca2+/calmodulin/CaMKII/CaV1.2 signaling in experimental models of Alzheimer's disease and vascular dementia.The up-regulation of voltage-gated sodium channels subtypes coincides with an increased sodium current in hippocampal neuronal culture model.The different metabolism of morusin in various species and its potent inhibition against UDP-glucuronosyltransferase (UGT) and cytochrome p450 (CYP450) enzymes.Up-regulation of GABA transporters and GABA(A) receptor α1 subunit in tremor rat hippocampus.Nucleotides maintain the activity of Cav1.2 channels in guinea-pig ventricular myocytes.Astragaloside IV Inhibits Membrane Ca[Formula: see text] Current but Enhances Sarcoplasmic Reticulum Ca[Formula: see text] Release.Decreased intracellular [Ca2+ ] coincides with reduced expression of Dhprα1s, RyR1, and diaphragmatic dysfunction in a rat model of sepsis.Lobe-related concentration- and Ca(2+)-dependent interactions of calmodulin with C- and N-terminal tails of the CaV1.2 channel.Abnormal changes in voltage-gated sodium channels subtypes NaV1.1, NaV1.2, NaV1.3, NaV1.6 and CaM/CaMKII pathway in low-grade astrocytoma.Electrophysiological effect and the gating mechanism of astragaloside IV on L-type Ca(2+) channels of guinea-pig ventricular myocytes.Nonylphenol affects myocardial contractility and L-type Ca(2+) channel currents in a non-monotonic manner via G protein-coupled receptor 30.The Effect of Ca, Lobe-Specificity, and CaMKII on CaM Binding to Na1.1Peripheral blood CD40-CD40L expression in human breast cancerBibliometric analysis of recent sodium channel research
P50
Q24304904-B51708A4-D7A0-4156-A55D-A531D047A7FDQ24322915-4B523B2C-3A0B-4A9A-BFAA-50F650041E84Q33566540-5299CDFA-CE5F-4493-888A-5AC796ABBAFEQ33843027-B11F566A-3566-4AAC-8358-6B996FBDFDBDQ35758458-8D67C4DA-9CE5-43C9-A3D3-16F96D6451C2Q36224808-588E5BA6-70E5-4FAD-AF4B-6980D910C54CQ39001848-BE4678C3-ED99-4936-B470-26A8C219D800Q39338810-225E4163-61CD-4B06-839F-83B46EE3833EQ39448577-D4BB6522-4404-4DD9-8B32-927C06E6BFE0Q40482362-FBF1F4BC-5FC8-415C-BB0E-3DE8E3C6B7D0Q41478083-5974D84A-14BD-42D3-89D9-3EBBCCEDA258Q43511477-06AC6CC1-42F1-4F44-A3DA-11B71427DA36Q43548494-C4FF54D9-8A24-404E-A25B-4A0094D50F97Q44362193-B2480370-61C3-4479-AF61-BEEF075A4C77Q45019147-6730E180-453C-4069-BB4F-BB0844B9C5E5Q45584675-DC29A67D-9980-4DDB-A823-8107632B49EEQ46809328-54DAA951-5E21-487F-9305-20E7EA4891C2Q46867869-9B24339F-5765-4A26-A1ED-871F632A7397Q48007345-B1F7A39F-1AD9-42B8-BE8E-ECADA22E9682Q50939620-B31311CD-0C81-4C88-84A5-3CC9E88550D0Q52631775-AC7A4C04-B268-4897-998A-0787D531C611Q53537653-25F034CB-69CC-47A2-B860-AA9436C61FC7Q53797510-08A58099-3012-4C34-BBA0-39CE5AD01774Q58710088-9DE2CB51-D1FC-4A73-B8D1-DBE8A2721C1EQ64127507-551BFDA3-D742-4EB3-B69F-C14BA08F9410Q91085029-9986650E-9200-4FC6-A9B2-89EF431477DD
P50
description
researcher (ORCID 0000-0001-9833-9691)
@en
name
Feng Guo
@en
type
label
Feng Guo
@en
prefLabel
Feng Guo
@en
P31
P496
0000-0001-9833-9691